2020
DOI: 10.3389/fneur.2020.00057
|View full text |Cite
|
Sign up to set email alerts
|

Beneficial Effects of Ketogenic Diet on Phosphofructokinase Deficiency (Glycogen Storage Disease Type VII)

Abstract: Background: A deficiency of muscle phosphofructokinase (PFKM) causes a rare metabolic muscle disease, the Tarui disease (Glycogen storage disease type VII, GSD VII) characterized by exercise intolerance with myalgia due to an inability to use glucose as an energy resource. No medical treatment for GSD VII currently exists. The aim of this study was to determine whether a dietary intervention with excessive fat intake would benefit GSD VII. Patient and Methods: A ketogenic diet (KD) intervention implemented as … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 25 publications
1
10
0
Order By: Relevance
“…Finally, there is a recent case study of a patient with phosphofructokinase deficiency (GSD VII, Tarui disease) who was treated with an MAD (ratio of ~1:1 fat/protein and carbohydrates restricted to 10 g/day) for 5 years. This therapy greatly alleviated muscle symptoms and improved exercise performance 125 . Taken together, these preliminary clinical observations suggest that KDs in one form or another have potential in ameliorating clinical symptoms in patients with GSD, and that such dietary interventions are not solely beneficial for blocking seizure activity.…”
Section: Kd Use In Glycogen Storage Disordersmentioning
confidence: 81%
See 1 more Smart Citation
“…Finally, there is a recent case study of a patient with phosphofructokinase deficiency (GSD VII, Tarui disease) who was treated with an MAD (ratio of ~1:1 fat/protein and carbohydrates restricted to 10 g/day) for 5 years. This therapy greatly alleviated muscle symptoms and improved exercise performance 125 . Taken together, these preliminary clinical observations suggest that KDs in one form or another have potential in ameliorating clinical symptoms in patients with GSD, and that such dietary interventions are not solely beneficial for blocking seizure activity.…”
Section: Kd Use In Glycogen Storage Disordersmentioning
confidence: 81%
“…This therapy greatly alleviated muscle symptoms and improved exercise performance. 125 Taken together, these preliminary clinical observations suggest that KDs in one form or another have potential in ameliorating clinical symptoms in patients with GSD, and that such dietary interventions are not solely beneficial for blocking seizure activity.…”
Section: Kd Use In Glycogen Storage Disordersmentioning
confidence: 88%
“…Also, favourable effects of high-fat diet in other types of GSDs with muscle involvement have been reported. Similä et al [20] observed that the muscle symptoms and exercise tolerance of the patient with GSD type VII improved during 5 years of KD. In contrast to these findings, Valayannopoulos et al [17] have emphasized that when exogenous D, L-3-hydroxybutyrate was received as a source of KBs, CK levels remained elevated in patients.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, phosphofructokinase deficiency (Tarui’s disease), a hereditary disorder that alters the ability of muscles to utilize carbohydrates (such as glucose) for energy production, was reported in patients suffering from muscle cramps, exercise intolerance and recurrent episodes of rhabdomyolysis during statin therapy [ 110 ]. Similar considerations have to be extended to other metabolic myopathies as muscle β-enolase deficiency, an ultrarare metabolic myopathy due to impairment of terminal glycolysis described in few adult patients with muscle fatigability, myalgia and increased CK values after intense physical exercise [ 111 , 112 , 113 ].…”
Section: Higher Risk With Statin Therapy: Role Of Comorbidity Genmentioning
confidence: 99%